Gamma-aminobutyric acid (GABA) receptor mediates suanzaorentang, a traditional Chinese herb remedy, -induced sleep alteration

Journal of Biomedical Science

Volumn 14, Issue 2, 2007, Pages 285-297

  Yi, Pei Lu ^a   Tsai, Chon Haw ^b   Chen, Ya Chu ^b   Chang, Fang Chia ^b,c  

^a JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

GABA; Non rapid eye movement sleep (NREMS); Rapid eye movement sleep (REMS); Suanzaorentang

Indexed keywords

2 HYDROXYSACLOFEN; 4 AMINOBUTYRIC ACID RECEPTOR; BICUCULLINE METHOBROMIDE; CHINESE DRUG; SUANZAORENTANG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHINESE HERB; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; ELECTROENCEPHALOGRAM; GABAERGIC TRANSMISSION; INSOMNIA; LIGHT DARK CYCLE; MALE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE; THERAPY EFFECT; TRADITIONAL MEDICINE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANIMALS; BACLOFEN; BICUCULLINE; DRUGS, CHINESE HERBAL; GABA ANTAGONISTS; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA; SLEEP STAGES; STARCH;

RATTUS;

EID: 34247267634     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-006-9137-z     Document Type: Article

References (54)

1. Partinen M., Epidemiology of sleep disorders, In: Kryger M.H., Roth T. and Dement W.C. (Eds.), Principles and Practice of Sleep Medicine. WB Saunders, Philadelphia, 1994, pp. 437-452.
2. Gillin J.C., Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? [Review]. Acta Psychiatricia Scandinavica Supplementum 393: 39-43, 1998.
3. Chung K.F. and Lee C.K.Y., Over-the-counter sleeping pills: a survey of use in Hong Kong and a review of their constituents. Gen. Hospital Psychiatry 24: 430-435, 2002.
4. Chen H.C. and Hsieh M.T., Clinical trial of suanzaorentang in the treatment of insomnia. Clin. Therapeut. 7: 334-337, 1985.
5. Chen H.C., Hsieh M.T. and Shibuya T., Suanzaorentang versus diazepam: a controlled double-blind study in anxiety. Int. J. Clin. Pharmacol, Therapy Toxicol. 24: 646-650, 1986.
6. Park J.H., Lee H.J., Koh S.M., Ban J.Y. and Seong Y.H., Protection of NMDA-induced neuronal cell damage by methanol extract of Zizyphi Spinosi Semen in cultured rat cerebellar granule cells. J. Ethnopharmacol. 95: 39-45, 2004.
7. Zheng H.Z., Dong A.H., and She J. (1997) (Eds) Modern Study of Traditional Chinese Medicine (in Chinese), Xue Yuan Press, Beijing, 1997.
8. Kanba S., Yamada K., Mizushima H., Murata T. and Asai M., Use of herbal medicine for treating psychiatric disorders in Japan, In: Kanba S. and Richelson E. (Eds.), Herbal Medicines for Neuropsychiatric Diseases: Current Developments and Research. Brunner/Mazel, New York, 1999, pp. 3-14.
9. Yu S.J. and Tseng J., Fu-ling, a Chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes. Int. J. Immunopharmacol. 18: 37-44, 1996.
10. Liao S.L., Kao T.K., Chen W.Y., Lin Y.S., Chen S.Y., Raung S.L., Wu C.W., Lu H.C. and Chen C.J., Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci. Lett. 372: 40-45, 2004.
11. Tsukamoto S., Wakana T., Koimaru K., Yoshida T., Sato M. and Ohta T., 7-Hydroxy)3-(4-hydroxybenzyl) chroman and Broussonin B: Neurotrophic compounds, isolated from Anemarrhena asphodeloides BUNGE, function as proteasome inhibitors. Biol. Pharmaceut. Bull. 28: 1798-1800, 2005.
12. Tsuda T., Kubota K., Yasuda K., Nishikawa S., Sugaya A. and Sugaya E., Effects of Chinese herbal medicine "kanbaku-taiso-to" on transmembrane ionic currents and its local anesthetic action. J. Ethnopharmacol. 17: 257-261, 1986.
13. Liao J.F., Jan Y.M., Huang S.Y., Wang H.H., Yu L.L. and Chen C.F., Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proc. Natl. Sci. Council, ROC - Part B, Life Sci. 19: 151-158, 1995.
14. McGinty D. and Szymusiak R., Hypothalamic regulation of sleep and arousal. Frontier. Biosci. 8: s1074-s1083, 2003.
15. Kukko-Lukjanov T.K. and Panula P., Subcellular distribution of histamine, GABA and galanin in tuberomamillary neurons in vitro. J. Chem. Neuroanatomy 25: 279-292, 2003.
16. Chang F.-C. and Opp M.R., Blockade of corticotropinreleasing hormone receptors reduces spontaneous waking in the rat. Am J Physiol 275: R793-R802, 1998.
17. Epstein A.M., Fitzsimons J.T. and Rolls B.J., Drinking induced by injection of angiotensin into the brain of the rat. J. Physiol. 210: 457-474, 1970.
18. Borbely A.A., A two process model of sleep regulation. Hum. Neurobiol. 1: 195-204, 1982.
19. Yi P.L., Tsai C.H., Lu M.K., Liu H.J., Chen Y.C., and Chang F.C. Interleukin)1b mediates sleep alteration in rotenone-induced parkinsonism rats. Sleep (under review process), 2006.
20. Hsieh M.T., Chen H.C., Kao H.C. and Shibuya T., Suanzaorentang and anxiolytic Chinese medicine, affects the central adrenergic and serotonergic systems in rats. Proc. Natl. Sci. Council, ROC -Part B, Life Sci. 10: 263-268, 1986.
21. Li Y., Wang R., Chen M., Wang Z. and Bi K., Pharmacodynamics study of suanzaoren decoction extracted by different technological process. Zhong Yao Cai 24: 884-885, 2001.
22. Hansen M.K., Kapas L., Fang J. and Krueger J.M., Cafeteria diet-induced sleep is blocked by subdiaphragmatic vagotomy in rats. Am. J. Physiol. 274: R168-R174, 1998.
23. Jenkins J.B., Omori T., Guan Z., Vgontzas A.N., Bixler E.O. and Fang J., Sleep is increased in mice with obesity induced by high-fat food. Physiol. Behav. 87: 255-262, 2006.
24. Roky R., Kapas L., Taishi P., Fang J. and Krueger J.M., Food restriction alters the diurnal distribution of sleep in rats. Physiol. Behav. 67: 697-703, 1999.
25. Rizzo P., Beelke M., De Carli F., Canovaro P., Nobili L., Robert A., Fornaro P., Tanganelli P., Regesta G. and Ferrillo F., Modifications of sleep EEG induced by chronic vagus nerve stimulation in patients affected by refractory epilepsy. Clin. Neurophysiol. 115: 658-664, 2004.
26. Valdes-Cruz A., Magdaleno-Madrigal V.M., Martinez-Vargas D., Fernandez-Mas R., Almazan-Alvarado S., Martinez A. and Fernandez-Guardiola A., Chronic stimulation of the cat vagus nerve: effect on sleep and behavior. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26: 113-118, 2002.
27. Vgontzas A.N., Papanicolaou D.A., Bixler E.O. and Chrousos G.P., Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 82: 1313-1316, 1997.
28. Kubota T., Fang J., Guan Z., Brown R.A. and Krueger J.M., Vagotomy attenuates tumor necrosis factor-alphainduced sleep and EEG delta-activity in rats. Am. J. Physiol. - Regulat. Integr. Comp. Physiol. 280: R1213-R1220, 2001.
29. Graeff F.G., Netto C.F. and Zangrossi H. Jr., The elevated T-maze as an experimental model of anxiety. Neurosci. Biobehav. Rev. 23: 237-246, 1998.
30. Ripoll N., Hascoet M. and Bourin M., Implication of 5-HT2 A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice. Behav Brain Res 166: 131-139, 2006.
31. Hilakivi I., Kovala T., Lappavuori A. and Shvaloff A., Effects of serotonin and noradrenaline uptake blockers on wakefulness and sleep in cats. Pharmacol. Toxicol. 60: 161-166, 1987.
32. Nicholson A.N. and Pascoe P.A., 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man. Neuropharmacology 25: 1079-1083, 1986.
33. Monti J.M. and Jantos H., Effects of the 5-HT1 A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat. Behav. Brain Res. 151: 159-166, 2004.
34. Popa D., Lena C., Fabre V., Prenat C., Gingrich J., Escourrou P., Hamon M. and Adrien J., Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. J. Neurosci. 25: 11231-11238, 2005.
35. Mendelson W.B., GABA-benzodiazepin-receptor chloride ionophore complex: Implications for the pharmacology of sleep, In: Wauquier A., Monti J.M. and Gaillard J.M. (Eds.), Sleep Neurotransmitters and Neuromodulators. Raven Press, New York, 1985, pp. 229.
36. Gottesmann C., GABA mechanisms and sleep. Neuroscience 111: 231-239, 2002.
37. A agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmacology 130: 285-291, 1997.
38. Von Krosigk M., Bal T. and McCormick D.A., Cellular mechanisms of a synchronized oscillation in thalamus. Science 261: 361-364, 1993.
39. Borbely A.A., Mattmann P., Loepfe M., Strauch I. and Lehmann D., Effects of benzodiazepine hypnotics on allnight sleep EEG spectra. Hum. Neurobiol. 4: 189-194, 1985.
40. Gaillard J.M., Schultz P. and Tissot R., Effects of three benzodiazepines (nitrazepam, flunitrazepam and bromazepam) on sleep of normal subjects, studied with an automatic scoring system. Pharmakopsychiatrie 6: 207-217, 1973.
41. Lancel M., Gronlein T.A.M. and Faulhaber J., Role of GABAA receptors in sleep regulation. Differential effects of muscimol and midazolam on sleep in rat. Neuropsychopharmacology 15: 63-74, 1996.
42. Mendelson W.B and Martin J.V., Effects of muscimol and flurazepam on the sleep EEG in the rat. Life. Sci. 47: 99-101, 1990.
43. Monti J.M. and Altier H., Flunitrazepam (Ro 5-4200) and sleep cycle in normal subjects. Psychopharmacologia 32: 343-349, 1973.
44. Gandolfo G., Scherschlicht R. and Gottesmann C., Benzodiazepines promote the intermediate stage at the expense of paradoxical sleep in the rat. Pharmacol. Biochem. Behav. 49: 921-927, 1994.
45. Borbely A.A. and Achermann P., Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics. Eur. J. Pharmacol. 195: 11-18, 1991.
46. Tobler I., Kopp C., Deboer T. and Rudolph U., Diazepaminduced changes in sleep: role of the aphpa 1 GABAA receptor subtype. Proc. Natl. Acad. Sci. USA 98: 6464-6469, 2001.
47. Declerck A.C., Ruwe F., O'Hanlon J.F. and Wauquier A., Effects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia. Psychopharmacology 106: 497-501, 1992.
48. Depoortere H., Francon D., Van Luijtelaar E.L.J.M., Drinkenburg W.H.I.M. and Coenen A.M.L., Differential effects of midazolam and zolpidem on sleep-wake states and epileptic activity in WAG/Rij rats. J. Pharmacol. Exp. Ther. 237: 649-658, 1995.
49. Gottesmann C., Trefouret S. and Depoortere H., Influence of Zolpidem, a novel hypnotic, on the intermediate stage and paradoxical sleep in rat. Pharmacol. Biochem. Behav. 47: 359-362, 1994.
50. B receptors decreases EEG synchronization. Neurosci. Lett. 172: 155-158, 2004.
51. Johnston G.A.R., Multiplicity of GABA receptors, In: Olsen R.W. and Venter J.C. (Eds.), Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties. Alan R. Liss, Inc., New York, (1986), pp. 57-71.
52. Enz R., Brandstatter J.H., Hartveit E., Wassle H. and Bormann J., Expression of GABA receptor rho 1 and rho 2 subunits in the retina and brain of rat. Eur. J. Neurosci. 7: 1495-1501, 1995.
53. C receptor in thyrotropin-secreting cells. Endocrinology 141: 1627-1632, 2000.
54. C receptor antagonist on sleep-wake behavior in rats. Psychopharmacology 154: 415-419, 2001.